Z-0265-2023Class II
B. Braun CARESITE Port Access Kit w/Tegaderm, REF 375214, Central Venous (cardiac) Catheter Tray (REF number...
Medical Action Industries, Inc. 306 / initiated 2022-09-15 / Terminated / root cause: labeling and UDI
Medical Action Industries, Inc. 306 began a recall of B. Braun CARESITE Port Access Kit w/Tegaderm, REF 375214, Central Venous (cardiac) Catheter Tray (REF number corrected 11/23/2022) on . FDA classified it as Class II and gives the reason as "The kits were incorrectly labeled with an extended expiration date of 02/21/2024 instead of 02/10/2024". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-0265-2023
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Medical Action Industries, Inc. 306
- Product
- B. Braun CARESITE Port Access Kit w/Tegaderm, REF 375214, Central Venous (cardiac) Catheter Tray (REF number corrected 11/23/2022)
- Product code
- OFF Central Venous Catheter Tray
- Reason for recall
- The kits were incorrectly labeled with an extended expiration date of 02/21/2024 instead of 02/10/2024.
- Root cause tag
- labeling and UDI
- FDA root cause
- Under Investigation by firm
- Action
- Owens & Minor/Medical Action INDUSTRIES, INC. issued an URGENT: MEDICAL DEVICE FIELD CORRECTION to its sole consignee on 09/23/2022 by email. The notices explained the issue and requested they take the following actions: "Please review your inventory, and segregate and quarantine all affected Kits. If any of the affected kits identified above were further distributed, please ensure all end-users are appropriately notified and maintain records of effectiveness. A labeling template is enclosed for printing labels which can be affixed on all affected kits in inventory. This label should be applied to each affected convenience kit and product case in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling. If you prefer to have labels printed for your facility, please send quantity and end-user information to [email protected]. Any adverse events associated with the use of the affected products should be reported to [email protected]. The FDA requires that we account for all affected products. Therefore, please complete the attached Response Form and return to [email protected] as soon as possible even if you have no current product inventory. If you have any questions, please send an email to [email protected]."
- Quantity in commerce
- 240 cases of 20 units
- Distribution
- US Nationwide distribution in the state of Pennsylvania.
- Product codes and lots
- UDI/DI 10809160283875, Batch/Lot number 298442
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0265-2023 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
